In 90 per cent of cases an acute hepatitis B infection heals spontaneously. There is no medication for the treatment of acute infections. A chronic infection requires treatment if it progresses: It is usually treated with antiviral medicines (nucleoside/nucleotide analoga) or with pegylated interferon. The aim is long-term viral load suppression and to reduce elevated liver enzymes in the bloodstream. Treatment takes between six to twelve months depending on developments (interferon) and several years (nucleoside/nucleotide analoga). If progression of the infection is mild, regular medical check-ups may suffice.
The treatment goal is cure. This should prevent secondary diseases, HCV-related liver diseases and advanced extrahepatic manifestations in particular. The new substances, Direct-Acting Antiviral agents (DAAs), which no longer need interferon, are all reimbursed by the health insurances since 1 Octobre 2017. Only hepatologists, gastroenterologists, infectious diseases specialists and some addiction specialists (see list) are allowed to prescribe these expensive medicines. Treatment takes 8, 12 or 24 weeks. Cost per treatment is around 30'000 Swiss Francs.
Recommendations on Treatment from SASL and SSI: https://sasl.unibas.ch/6SASLguidelines.php
EASL Recommendations Hepatitis C 2015: http://www.easl.eu/medias/cpg/HEPC-2015/Full-report.pdf